Biktarvy and Complera are two prominent antiretroviral medications used in the management of HIV infection. As the landscape of HIV treatment continues to evolve, patients and healthcare providers are often faced with the challenge of selecting the most suitable therapy to ensure effective viral suppression while minimizing side effects. Both Biktarvy and Complera have demonstrated efficacy in clinical trials, but they differ in their compositions, mechanisms of action, and dosing regimens. Understanding these differences is crucial for patients who are navigating the complexities of HIV treatment. Factors such as adherence to the medication regimen, potential side effects, and the patient’s overall health condition play significant roles in determining the best…